Business Model & Revenue
Sleep Number Corporation (NASDAQ: SNBR) is a Minneapolis-based sleep technology company founded in 1987. The company designs, manufactures, and markets Sleep Number smart beds — adjustable air-chamber mattresses with sleep tracking technology, IoT integration, and partner ecosystem (Oura ring, Google Home, Apple HealthKit).
Revenue model: Direct sales through company-owned retail stores (600+ locations across the US) and e-commerce. The company does not sell through third-party retailers. Average ticket price is $3,000+, positioning Sleep Number at the premium end of the mattress market.
Key products: Sleep Number 360 smart bed line (multiple tiers from c2 to i8), Sleep Number smart bed bases, SleepIQ technology platform. The company generates recurring revenue through bed accessories, sleep tracking subscriptions, and service/warranty.
Target market: Health-conscious consumers willing to pay a premium for sleep optimization. The smart bed tracks sleep metrics (heart rate, breathing, movement) and adjusts firmness automatically. The company positions itself as a health and wellness company, not just a mattress company.
Competitive challenge: The mattress market has been disrupted by DTC brands (Casper, Nectar, Purple, Helix) offering foam mattresses at 1/5th the price with free home delivery. Mattress Firm (now owned by Tempur Sealy) and big-box retailers provide further competition. Sleep Number's premium pricing and technology differentiation have not been sufficient to prevent multi-year market share decline.
Financial Highlights
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $1,411M | $1,682M | $1,887M | $2,114M |
| Revenue Growth | -16.1% | -10.9% | -10.7% | -3.2% |
| Gross Profit | $832.9M | $1,003M | $1,089M | $1,202M |
| Gross Margin | 59.0% | 59.6% | 57.7% | 56.9% |
| Operating Income | ($46.6)M | $22.9M | $22.9M | $67.9M |
| Net Income | ($131.9)M | ($20.3)M | ($15.3)M | $36.6M |
| EPS | ($5.77) | ($0.90) | ($0.68) | $1.63 |
| FCF | ($17.7)M | $3.6M | ($66.1)M | ($33.3)M |
Key Metrics
| Metric | Value |
|---|---|
| Market Cap | ~$64M |
| Shares Outstanding | 22.9M |
| Enterprise Value | ~$700M+ (includes $616M debt) |
| Price/Sales (TTM) | 0.045x |
| Cash | ~$120M |
| Total Debt | ~$616M |
| Interest Expense | $49.4M/year |
| 52-Week Range | ~$1.50 - $8.00 |
| Analyst PT | $4.50 (Hold consensus) |
| Retail Locations | 600+ |
Valuation Comparison
| Metric | SNBR | Context |
|---|---|---|
| Market Cap | $64M | For $1.4B revenue company |
| Price/Sales | 0.045x | Industry average: 0.8-1.5x |
| EV/Revenue | ~0.5x | Reasonable for distressed retailer |
| EV/EBITDA | NM | Negative EBITDA |
| Debt/Equity | ~9.6x | Highly leveraged |
The Deterioration (4 Years)
| Year | Revenue | Net Income | Trend |
|---|---|---|---|
| FY2022 | $2,114M | $36.6M | Peak |
| FY2023 | $1,887M | ($15.3)M | ⬇️ |
| FY2024 | $1,682M | ($20.3)M | ⬇️ |
| FY2025 | $1,411M | ($131.9)M | ⬇️ |
| Change | -33% | Decline | Accelerating |
Competitive Landscape
The mattress and sleep industry is highly competitive and has undergone massive disruption:
- Tempur Sealy (TPX): Market leader. Acquired Mattress Firm in 2023, creating the largest mattress retail network. $5B+ revenue.
- Serta Simmons Bedding: Major competitor, emerged from bankruptcy restructuring. Brands include Serta, Beautyrest.
- Purple Innovation (PRPL): DTC foam mattress company with patented Hyper-Elastic Polymer. $500M+ revenue.
- Casper Sleep (CSPR): DTC pioneer, now publicly traded. Known for the "one perfect mattress" concept. $500M+ revenue.
- Eight Sleep: Direct competitor in smart bed/sleep tech. Temperature-controlled mattress pad with sleep tracking. Private company, $500M+ valuation.
- Amazon Basics, Nectar, Zinus: Ultra-low-cost foam mattresses on Amazon. Queen mattresses for $200-500. The price floor keeps dropping.
Sleep Number's problem: The company occupies an awkward middle ground — too expensive for the mass market, not differentiated enough (despite smart bed tech) for the luxury segment. Eight Sleep offers better sleep tracking at a lower price point. Tempur Sealy offers better brand recognition through Mattress Firm's retail footprint. DTC brands offer simpler products at 1/5th the price. Sleep Number's competitive moat — the adjustable air chamber and proprietary sleep tracking — hasn't been sufficient to prevent 4 consecutive years of revenue decline.
Catalysts
-
Q1 2026 earnings (April 29, 2026): The immediate catalyst. Revenue trend, margin trajectory, and Q2 guidance will determine the stock's direction. Any sign of stabilization could drive the stock to $4+.
-
Q2 revenue stabilization: CEO has guided for flat second-half sales. If achieved, it would mark the inflection point.
-
Debt restructuring: The $616M debt load is the biggest overhang. Any refinancing, maturity extension, or reduction would be a major positive.
-
Cost cutting: The company has already cut costs significantly. Further reductions in store count or headcount could improve the path to profitability.
-
New product launches: Sleep Number's 360 smart bed ecosystem with IoT features could drive upgrades and higher margins.
-
Takeout potential: At $64M market cap, Sleep Number could be acquired by a private equity firm or larger mattress company for its retail footprint and brand.
Key Risks
- Revenue has declined every year since FY2021 ($2.19B → $1.41B). No evidence the decline has bottomed.
- $132M net loss in FY2025. The company is deeply unprofitable.
- $49.4M annual interest expense on $616M in debt. The debt burden is crushing.
- Market share loss to DTC brands (Casper, Nectar, Purple) and big-box retailers (Mattress Firm, Tempur Sealy).
- Average ticket price of $3,000+ is a hard sell in a trade-down consumer environment.
- Smart bed category remains niche. Never achieved mainstream adoption despite 20+ years in market.
- 600+ retail locations carry significant lease obligations and overhead.
- Pre-earnings timing makes this a binary bet, not a fundamentals-based investment.
- Analyst consensus is Hold — no Buy ratings from Wall Street.
- Cash burn: FCF was ($17.7M) in FY2025. Limited runway without debt restructuring.
Our Thesis
Sleep Number at $2.80 is a paradox. On paper, a company doing $1.41B in revenue with $833M gross profit trading at a $64M market cap is absurd — that's 0.045x sales and 0.08x gross profit. If the company can simply stop bleeding, the stock could double or triple. The analyst $4.50 price target implies a 60% return.
But the market is pricing in continued deterioration for good reason. Revenue has declined for four consecutive years. The company lost $132M in FY2025, burning more in interest ($50M) than it generates in operating profit. The smart bed category — adjustable air chambers, sleep tracking, IoT integration — is a niche that never went mainstream. Consumers increasingly choose $300-800 foam mattresses from DTC brands or big-box retailers. Sleep Number's average ticket price of $3,000+ is a tough sell when the economy is soft and consumers are trade-down.
Q1 earnings (tomorrow) will be the key test. If revenue declines accelerate or management withdraws the Q2 stabilization guidance, the stock could retest $2. If the company shows any sign of bottoming — even flat revenue sequentially — the $4.50 analyst target becomes achievable. This is a coin flip. Neutral because the pre-earnings timing eliminates any analytical edge.
Get reports like this delivered free
New small-cap research every week. No paywall, no fluff.